和田怀孕15天能测出来和田割包皮后要住院么,和田验孕棒二条杠,和田包皮手术治疗时间,和田上环多钱,和田测纸一深一浅是怀孕了吗,和田节育环几年取,和田看妇科病哪家好

White House communications director Hope Hicks is not answering questions about her time in the White House during her closed-door House Intelligence Committee testimony Tuesday, but she has started to answer some questions about the presidential transition, according to lawmakers on the committee.A source familiar with her testimony says the attorney for Hicks told the committee that she will not discuss matters after the campaign in accordance with the White House request. When asked about certain matters, her attorney says she will "take it under advisement" but not answer those questions, the source said.When former White House chief strategist Steve Bannon appeared before the committee last month and didn't answer questions about similar time frame beyond the 2016 campaign, he was hit with a subpoena during the interview. Republicans said Bannon's claim that he could invoke executive privilege?during the presidential transition did not have merit.Hicks, however, did respond to some questions regarding the transition, according to Rep. Tom Rooney, a Florida Republican.Rooney said her answers weren't prompted by a subpoena threat, but because she apparently had responded to similar questions during her previous interview before the Senate Intelligence Committee. The committee made the case they were entitled to the same answers as the Senate panel, and the White House apparently agreed."It had more to do with what she testified to the Senate, and what was fair to the House to ask the same questions," Rooney said.It's unclear whether Hicks is answering all questions about the transition or just those that she previously answered in her Senate testimony.Earlier on Tuesday, Democrats were pushing for the committee to subpoena Hicks for not responding to the panel's questions."We got Bannon-ed," said Rep. Denny Heck, a Washington state Democrat."I have less hope we'll get to all the answers," said Rep. Mike Quigley, an Illinois Democrat. "As with anyone who doesn't answer questions, they ought to be subpoenaed."Rooney and other lawmakers said Hicks still was not answering questions about her time in the Trump White House."There are some questions that she's not going to answer. I think anything dealing with the administration, from the time of the inauguration," GOP Rep. Chris Stewart of Utah told reporters.Rep. Mike Conaway, the Texas Republican leading the House Intelligence Committee's Russia investigation, told CNN ahead of the meeting that he expected Hicks to answer all of the committee's questions. He declined to comment Tuesday afternoon on Hicks' testimony or a possible subpoena, saying he would wait until the interview had concluded.Bannon returned under subpoena earlier this month to the committee to continue he testimony, and he told the panel he had been instructed by the White House to invoke executive privilege on behalf of the President.California Rep. Adam Schiff, the top Democrat on the House Intelligence Committee, has called for Bannon to be held in contempt of Congress for refusing to answer questions, as well as former Trump campaign manager Corey Lewandowski, who also limited the scope of questions he would answer. But Conaway said Tuesday that he still has to discuss the matter with House Speaker Paul Ryan before deciding how to proceed.Quigley said Hicks had not asserted privilege Tuesday, but she was "following the orders of the White House not to answer certain questions."Hicks did not answer reporter questions on her way into the interview Tuesday morning. She was initially scheduled to appear before the committee last month as part of the panel's investigation into Russian meddling into the US election, but her interview was delayed over questions about the scope of her testimony.Hicks has already been interviewed by the Senate Intelligence Committee, a source familiar with the matter told CNN. Hicks also met last year with?special counsel Robert Mueller as part of his investigation.Hicks, a trusted Trump aide for years, was one of then-candidate Trump's first hires as he put together an improbable run for the White House. During the campaign, she was often by Trump's side and attended nearly every rally, while she was in frequent communication with other senior officials as they coordinated their tactics to win the White House.The House panel plans to interview her about any knowledge she has of contacts that occurred between other Trump associates and Russians. And she is bound to be questioned about other controversies as well, namely the White House's involvement in crafting a misleading response last summer once a June 2016 meeting between Russians and Donald Trump Jr. was revealed in the press.Hicks appears to have firsthand knowledge of a number of key events that have shaped the first year of the Trump White House, including being on Air Force One when the initial misleading statement about Trump Jr.'s meeting with Russians was crafted. 4977

WEST PALM BEACH, Fla. — While the demand for guns is cooling off, sellers say there is still a nationwide shortage of ammunition, and it's unclear when inventory will return to normal.The owner of Guns and Range Training Center in West Palm Beach said most gun sales during the COVID-19 pandemic have been to first-time buyers, making up 80% of sales.Gun owner Rita Gonzalez is no beginner, and this year she has helped many of her friends become first-time gun owners."Just with everything going on and stuff, they just feel safer having them," Gonzalez said. "It's like my happy place. I go. I shoot. I release stress. I like it." 640

What does GSA being allowed to preliminarily work with the Dems have to do with continuing to pursue our various cases on what will go down as the most corrupt election in American political history? We are moving full speed ahead. Will never concede to fake ballots & “Dominion”.— Donald J. Trump (@realDonaldTrump) November 24, 2020 346

When Brooke Harrison picked up her backpack Sunday during orientation day at Marjory Stoneman Douglas High School, there were two things different about it. A blue name tag made out of tape and a bullet hole near the bottom. FULL COVERAGE: Parkland school shooting“(The bullet) could have gone through my backpack, but I’m pretty sure it just grazed it or slightly passed it. The fact that my backpack was so close to me is really mind blowing,” Brooke said.It was left in her freshman classroom where five classmates were shot. Three of them died: Alyssa Alhadeff, Alex Schachter and Alaina Petty. Seventeen people died in total. “We know how lucky we are,” said Brooke’s mom, Denise Harrison. “From the stories we already heard in the classroom, we go pick up the backpack we saw this. Everyday, we’re saying to ourselves, we’re so lucky.”On Wednesday, Brooke and the student body return to campus.“It’s going to be sad because I’m going to remember the fact that three of my classmates won’t be able to go back to school and that three of them won’t be able to see their friends and see that everyone is okay,” Brooke said. Her parents aren’t worried about Wednesday or the next day. They know security will be tight when they return, but beyond that there's uncertainty.“One of the greater concerns that we have is, what happens next?” said Robert Harrison, Brooke’s dad. “When the news cycle ended and six months have gone by, what actions will have been taken to ensure this doesn’t ever happen again? At this school or any other.” For starters, they want more armed school resource officers and a review of code red protocol. “To give ourselves as parents, to give us the ability to know when you drop your kid off, they’re going to be safe,” Harrison said. On top of the friends they lost, they lost their innocence. Every hug and every “I love you” means more now. “Time just feels more precious now. It feels like we have to reaffirm that. I know they love me, and I know I love them, but it feels like we need to say it more now,” Brooke said. Brooke’s parents have been through tragedy before. They lived just two blocks away from the World Trade Center during the 9/11 attack. 2277

When he was diagnosed with two autoimmune diseases, Joel Hechler knew he’d be in for a battle. He didn’t realize maybe his toughest one would be with his insurance company.“I think they put the dollars ahead of a patient’s health,” Hechler said. “I don’t think they fully understand the impact the medicine will have on my long-term health and well-being."Hechler suffers from Crohn’s disease and ulcerative colitis, diseases that attack the lining of his digestive tract. Autoimmune conditions like his can’t be cured but, with the right medication, the symptoms can be controlled.  Finding the right medicine can be hard for those suffering from autoimmune diseases. Even if there are scores of drugs on the market, some patients might only respond to one. In Joel’s case, his doctor thought he’d have a better chance trying a drug called Remicade.“I received a letter from my insurance company that denied the Remicade on the basis that I have to try a different drug before I can get to Remicade," Hechler said.Hechler's insurance company, Premera Blue Cross, wouldn’t approve the drug his doctor prescribed because they wanted him to try a cheaper one first.It’s part of a program that health insurers nationwide use called step therapy, requiring that patients try less-costly drugs before “stepping up” to more expensive ones — even if doctors believes the cheaper drug won’t work.Dr. Larry Adler is president of Huron Gastro in Ypsilanti, Michigan and says he spends virtually every day battling insurance companies over step therapy drugs.“They have to fail this medicine first before they get the new drug,” Adler said. “That doesn’t make any sense.”Adler says it's common for patients to get sicker while waiting for step therapy to run its course.In Hechler's case, it took six weeks of fighting with his insurer to convince them that the cheaper drug wouldn’t be effective. As he was waiting, he was getting worse.“It got to the point where I had to be admitted to the hospital,” Hechler said. "I was very, very sick.”Step therapies are used by insurers to try to control skyrocketing prescription medicine costs, says Glen Perry, Director of Pharmacy Contracting and Sales for Blue Cross Blue Shield of Michigan.“These drugs can cost up to 0,000 per year. These are not cheap medications,” Perry said.“It seems like you’re telling patients that, in many cases, your insurer knows what’s best for you, rather than your doctor,” Jones said.“We are trying to provide the most cost effective and safe medication use,” Perry said, adding that when a doctor and insurer disagree over a drug, they can usually resolve the case within a few days without putting a patient at serious risk.“A delay of one or two days I don’t think is really going to make that much of a difference for the medical outcome of the patient," he said.But for many patients, like Phyllis Toole, the delay is longer than a few days.Phyllis suffers from rheumatoid arthritis, a condition where her body attacks her joints. When her doctor wanted to put her on Orencia, her insurance company HAP said she needed to first try a less expensive drug, Humira.But Phyllis’ doctor was worried about possible side effects and thought Humira could be risky.After battling for months, Phyllis says the whole thing made her feel more like a number than a patient. With her doctor and insurer in a standoff, she was forced to rely on samples of the drug she got from her doctor. HAP never approved her prescription.“They’re playing doctor, is what it feels like,” Toole said. “They’re saying this is what you can have for the symptoms you have. It may make you sicker, but this is what you can have.”HAP issued the following statement to Scripps station WXYZ in Detroit: 3800